| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/13/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 8.3k | $12.59 | $104.1k | | 07/12/2023 |
| 07/12/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 3.2k | $14.08 | $44.5k | | 07/12/2023 |
| 07/12/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 3.2k | $13.18 | $42.1k | | 07/12/2023 |
| 07/12/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 78.1k | $12.15 | $948.3k | | 07/12/2023 |
| 07/12/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Sale | Class A Common Stock | 24.3k | $11.25 | $273.4k | | 07/12/2023 |
| 04/04/2023 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 2.2k | $29.09 | $63.6k | | 04/03/2023 |
| 04/03/2023 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 2.5k | $30.31 | $74.4k | | 04/03/2023 |
| 03/31/2023 | Beam Therapeutics Inc. | BEAM | Grant | Common Stock | 20k | $0.00 | $0 | | 01/31/2023 |
| 01/31/2023 | Beam Therapeutics Inc. | BEAM | Grant | Stock Option (Right to Buy) | 20k | $43.45 | $869k | | 01/31/2023 |
| 01/27/2023 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 36.2k | $45.08 | $1.6M | | 01/26/2023 |
| 01/27/2023 | Beam Therapeutics Inc. | BEAM | Exercise | Stock Option (Right to Buy) | 36.2k | $13.68 | $494.6k | | 01/26/2023 |
| 01/26/2023 | Beam Therapeutics Inc. | BEAM | Exercise | Stock Option (Right to Buy) | 1.1k | $13.68 | $15.1k | | 01/26/2023 |
| 01/26/2023 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 1.1k | $45.16 | $49.8k | | 01/26/2023 |
| 01/24/2023 | Beam Therapeutics Inc. | BEAM | Exercise | Stock Option (Right to Buy) | 14.8k | $13.68 | $202.6k | | 01/23/2023 |
| 01/24/2023 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 14.8k | $45.01 | $666.7k | | 01/23/2023 |
| 01/23/2023 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 5.4k | $45.02 | $244.3k | | 01/23/2023 |
| 01/23/2023 | Beam Therapeutics Inc. | BEAM | Exercise | Stock Option (Right to Buy) | 5.4k | $13.68 | $74.2k | | 01/23/2023 |
| 01/18/2023 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 47.2k | $45.14 | $2.1M | | 01/18/2023 |
| 01/18/2023 | Beam Therapeutics Inc. | BEAM | Exercise | Stock Option (Right to Buy) | 39.9k | $13.68 | $545.6k | | 01/18/2023 |
| 01/03/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.8k | $0.00 | $0 | | 01/03/2023 |
| 10/03/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.3k | $0.00 | $0 | | 10/03/2022 |
| 07/01/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.6k | $0.00 | $0 | | 07/01/2022 |
| 06/14/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 18.1k | $0.00 | $0 | | 06/14/2022 |
| 06/14/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Stock Option (right to buy) | 36.3k | $6.20 | $225k | | 06/14/2022 |
| 04/01/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.8k | $0.00 | $0 | | 04/01/2022 |
| 03/31/2022 | Beam Therapeutics Inc. | BEAM | Grant | Common Stock | 15k | $0.00 | $0 | | 03/31/2022 |
| 03/31/2022 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 1.8k | $59.11 | $105.6k | | 03/31/2022 |
| 01/31/2022 | Beam Therapeutics Inc. | BEAM | Grant | Stock Option (Right to Buy) | 30k | $69.21 | $2.1M | | 01/31/2022 |
| 01/03/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 763 | $0.00 | $0 | | 01/03/2022 |
| 10/01/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 629 | $0.00 | $0 | | 10/01/2021 |
| 07/01/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 382 | $0.00 | $0 | | 07/01/2021 |
| 06/30/2021 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 15k | $117.00 | $1.8M | | 06/30/2021 |
| 06/30/2021 | Beam Therapeutics Inc. | BEAM | Sale | Common Stock | 15k | $127.00 | $1.9M | | 06/30/2021 |
| 06/30/2021 | Beam Therapeutics Inc. | BEAM | Exercise | Stock Option (Right to Buy) | 30k | $13.68 | $410.4k | | 06/30/2021 |
| 04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Other (acquisition) | Class A Common Stock | 126.6k | $0.00 | $0 | | 04/20/2021 |
|